Log In
Print this Print this

Benet, risedronate (once-monthly Actonel, once-monthly Benet) (NE-58095)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionAntiresorptive pyridinyl bisphosphonate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation
PartnerAjinomoto Co. Inc.;
Eisai Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today